Skip to main content

Published locations for Greater fracture risk reduction seen with denosumab vs. zoledronic acid in postmenopausal women

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Greater fracture risk reduction seen with denosumab vs. zoledronic acid in postmenopausal women

User login

  • Reset your password
  • /content/greater-fracture-risk-reduction-seen-denosumab-vs-zoledronic-acid-postmenopausal-women
  • /clinicianreviews/article/265955/osteoporosis/greater-fracture-risk-reduction-seen-denosumab-vs
  • /familypracticenews/article/265955/osteoporosis/greater-fracture-risk-reduction-seen-denosumab-vs
  • /fedprac/article/265955/osteoporosis/greater-fracture-risk-reduction-seen-denosumab-vs-zoledronic
  • /internalmedicinenews/article/265955/osteoporosis/greater-fracture-risk-reduction-seen-denosumab-vs
  • /obgynnews/article/265955/osteoporosis/greater-fracture-risk-reduction-seen-denosumab-vs-zoledronic
  • /rheumatologynews/article/265955/osteoporosis/greater-fracture-risk-reduction-seen-denosumab-vs
  • /clinicalendocrinologynews/article/265955/osteoporosis/greater-fracture-risk-reduction-seen-denosumab
  • /obgyn/article/265955/osteoporosis/greater-fracture-risk-reduction-seen-denosumab-vs-zoledronic-acid
  • /endocrinology/article/265955/osteoporosis/greater-fracture-risk-reduction-seen-denosumab-vs
  • /rheumatology/article/265955/osteoporosis/greater-fracture-risk-reduction-seen-denosumab-vs
  • /internalmedicine/article/265955/osteoporosis/greater-fracture-risk-reduction-seen-denosumab-vs
  • /familymedicine/article/265955/osteoporosis/greater-fracture-risk-reduction-seen-denosumab-vs